Evidence map›Paper›PMID 29142479›Full record

ArticleWorld journal of gastroenterology2017

Medication beliefs predict medication adherence in ambulatory patients with decompensated cirrhosis.

Kelly L Hayward, Patricia C Valery, Jennifer H Martin, Antara Karmakar, Preya J Patel, Leigh U Horsfall, Caroline J Tallis, Katherine A Stuart, Penny L Wright, David D Smith and 3 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Polypharmacy in chronic liver disease patients: Implications for disease severity, drug-drug interaction, and quality of life.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Novel Agents in the Management of Hepatic Encephalopathy: A Review.Journal of clinical and translational hepatology · 2021
    Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Kelly L HaywardPharmacy Department, Princess Alexandra Hospital, The Centre for Liver Disease Research, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland 4102, Australia.
Patricia C ValeryCancer and Chronic Disease Research Group, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia.
Jennifer H MartinSchool of Medicine and Public Health, The University of Newcastle, Callaghan, New South Wales 2308, Australia.
Antara KarmakarThe Centre for Liver Disease Research, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland 4102, Australia.
Preya J PatelDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, The Centre for Liver Disease Research, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland 4102, Australia.
Leigh U HorsfallDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, The Centre for Liver Disease Research, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland 4102, Australia.
Caroline J TallisDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.
Katherine A StuartDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.
Penny L WrightDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, Woolloongabba, Queensland 4102, Australia.
David D SmithStatistics Unit, QIMR Berghofer Medical Research Institute, Herston, Queensland 4006, Australia.
Katharine M IrvineDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, The Centre for Liver Disease Research, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland 4102, Australia.
Elizabeth E PowellDepartment of Gastroenterology and Hepatology, Princess Alexandra Hospital, The Centre for Liver Disease Research, Translational Research Institute, The University of Queensland, Woolloongabba, Queensland 4102, Australia.
W Neil CottrellSchool of Pharmacy, The University of Queensland, Woolloongabba, Queensland 4102, Australia. n.cottrell@uq.edu.au.
University of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo investigate the impact of medication beliefs, illness perceptions and quality of life on medication adherence in people with decompensated cirrhosis.

methodsOne hundred adults with decompensated cirrhosis completed a structured questionnaire when they attended for routine outpatient hepatology review. Measures of self-reported medication adherence (Morisky Medication Adherence Scale), beliefs surrounding medications (Beliefs about Medicines Questionnaire), perceptions of illness and medicines (Brief Illness Perception Questionnaire), and quality of life (Chronic Liver Disease Questionnaire) were examined. Clinical data were obtained

resultsMedication adherence was "High" in 42% of participants, "Medium" in 37%, and "Low" in 21%. Compared to patients with "High" adherence, those with "Medium" or "Low" adherence were more likely to report difficulty affording their medications (

conclusionThe association between "Low" adherence and patients having strong concerns or doubting the necessity or helpfulness of their medications should be explored further given the clinical relevance.

Indexed as

CultureHealth Knowledge, Attitudes, PracticeQuality of LifeAgedCross-Sectional StudiesDrug MonitoringFemaleHumansLiver CirrhosisMaleMedication AdherenceMiddle AgedPerceptionSelf ReportIllness perceptionsLiver cirrhosisMedication adherenceMedication beliefsQuality of life

Identifiers

PMID29142479
PMCPMC5677197
OpenAlexW2767162090

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.